3H Health Investment

Total investments

18

Average round size

49M

Portfolio companies

14

Lead investments

3

Follow on index

0.17

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologyHealth CareGeneticsManufacturingMedical DeviceMedicalLife SciencePharmaceuticalTherapeuticsBiopharma

Investments analytics

Analytics

Total investments
18
Lead investments
3
Follow on index
0.17
Investments by industry
  • Health Care (8)
  • Biotechnology (6)
  • Pharmaceutical (5)
  • Medical Device (4)
  • Medical (3)
  • Show 7 more
Investments by region
  • China (16)
  • United States (1)
Peak activity year
2020
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
6
Avg. valuation at time of investment
78M
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Angitia Biopharmaceuticals 19 Oct 2023 Biotechnology, Health Care, Medical, Biopharma Early Stage Venture 46M Guangdong, Guangzhou, China
CIARRA 02 Sep 2022 E-Commerce, Smart Home Early Stage Venture Guangdong, Foshan, China
EdiGene 21 Apr 2021 Biotechnology, Health Care, Genetics Early Stage Venture 61M Beijing, Dongcheng District, China

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.